Angiopoietin-2 Deficiency Decelerates Age-Dependent Vascular Changes in the Mouse Retina

Retinae of aged humans show signs of vascular regression. Vascular regression involves a mismatch between Angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF) expression. We used heterozygous Ang-2 deficient (Ang2LacZ) mice to evaluate murine retinal vascular changes and gene expression of growth factors. Vascular changes were assessed by quantitative retinal morphometry and gene expression levels of growth factors were measured by quantitative PCR. The numbers of endothelial cells and pericytes did not change in the Ang2LacZ retinae with age, whereas they decreased throughout the age spectrum studied in the wild type retinae. Moreover, vascular regression significantly decelerated in the heterozygous Ang2LacZ retinae (200% to 1 month), while the formation of acellular capillaries was significantly increased at 13 months in the wild type retinae (340% to 1 month). Gene expression analysis revealed that VEGF, Ang-1, PDGF-B and Ang2 mRNA levels were decreased in the wild type retinae at 9 month of age. However, the decrease of Ang-2 was smaller compared with other genes. While VEGF levels dropped in wild type mice up to 60% compared to 1 month, VEGF increased in heterozygous Ang-2 deficient retinae at an age of 9 months (141% to 1 month). Similarly, Ang-1 levels decreased in wild type mice (45% to 1 month), but remained stable in Ang2LacZ mice. These data suggest that Ang-2 gene dose reduction decelerates vasoregression in the retina with age. This effect links to higher levels of survival factors such as VEGF and Ang-1, suggesting that the ratio of these factors is critical for capillary cell survival.

[1]  H. Hammes,et al.  Impaired pericyte recruitment and abnormal retinal angiogenesis as a result of angiopoietin-2 overexpression , 2006, Thrombosis and Haemostasis.

[2]  T. Chan-Ling,et al.  Altered pericyte–endothelial relations in the rat retina during aging: Implications for vessel stability , 2006, Neurobiology of Aging.

[3]  A. Wagatsuma Effect of aging on expression of angiogenesis-related factors in mouse skeletal muscle , 2006, Experimental Gerontology.

[4]  H. Hammes,et al.  Endothelial survival factors and spatial completion, but not pericyte coverage of retinal capillaries, determine vessel plasticity , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  C. Betsholtz,et al.  Endothelial/Pericyte Interactions , 2005, Circulation research.

[6]  A. Kotanidou,et al.  Angiopoietin-2 Causes Inflammation in Vivo by Promoting Vascular Leakage , 2005, Journal of Pharmacology and Experimental Therapeutics.

[7]  H. Hammes,et al.  Pericytes and the Pathogenesis of Diabetic Retinopathy , 2005, Diabetes.

[8]  Gavin Thurston,et al.  Age-Related Changes in Vascular Endothelial Growth Factor Dependency and Angiopoietin-1–Induced Plasticity of Adult Blood Vessels , 2004, Circulation research.

[9]  H. Hammes,et al.  Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. , 2004, Diabetes.

[10]  P. Carmeliet Angiogenesis in health and disease , 2003, Nature Medicine.

[11]  H. Hammes,et al.  Endothelium‐specific platelet‐derived growth factor‐B ablation mimics diabetic retinopathy , 2002, The EMBO journal.

[12]  Richard A. Lang,et al.  Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Bursell,et al.  Suppression of diabetic retinopathy with angiopoietin-1. , 2002, The American journal of pathology.

[14]  J. Lawrenson,et al.  Pericytes: Cell Biology and Pathology , 2001, Cells Tissues Organs.

[15]  Y. G. Kim,et al.  Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  P. Campochiaro,et al.  Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization , 2000, Journal of cellular physiology.

[17]  N. Glazer,et al.  Angiopoietin-1 protects the adult vasculature against plasma leakage , 2000, Nature Medicine.

[18]  Thomas N. Sato,et al.  Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.

[19]  C. Betsholtz,et al.  Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. , 1999, Development.

[20]  B R Johansson,et al.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.

[21]  Douglas Hanahan,et al.  Signaling Vascular Morphogenesis and Maintenance , 1997, Science.

[22]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[23]  H. Hammes,et al.  Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor–type integrins inhibits retinal neovascularization , 1996, Nature Medicine.

[24]  P. Henkind,et al.  Aging changes in the retinal capillary bed of the rat. , 1979, Microvascular research.

[25]  D TOUSSAINT,et al.  Retinal vascular patterns. IV. Diabetic retinopathy. , 1961, Archives of ophthalmology.

[26]  D. Cogan,et al.  Retinal Vascular Patterns: Part III. Age, Hypertension, Absolute Glaucoma, Injury , 1961 .

[27]  D. Cogan,et al.  Retinal vascular patterns. III. Age, hypertension, absolute glaucoma, injury. , 1961, Archives of ophthalmology.